1. Tumor regression mediated by oncogene withdrawal or erlotinib stimulates infiltration of inflammatory immune cells in EGFR mutant lung tumors. Issue 1 (10th July 2019) Authors: Ayeni, Deborah; Miller, Braden; Kuhlmann, Alexandra; Ho, Ping-Chih; Robles-Oteiza, Camila; Gaefele, Mmaserame; Levy, Stellar; de Miguel, Fernando J.; Perry, Curtis; Guan, Tianxia; Krystal, Gerald; Lockwood, William; Zelterman, Daniel; Homer, Robert; Liu, Zongzhi; Kaech, Susan; Politi, Katerina Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗